site stats

Evofem biosciences investor relations

Web© 2024 Evofem Biosciences, Inc. For investor discussions only. 7 “Best in Class” Sales Team •70 women’s health sales reps and regional managers WebJan 18, 2024 · However, while Evofem may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Evofem's views as of any date subsequent to the date hereof. Evofem Biosciences Contact: Marcy Graham …

EVFM Company Profile & Executives - Evofem Biosciences Inc.

WebEvofem Biosciences, Inc., (OTCQB: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address … Web2 days ago · — Improves Phexxi coverage for more than 5.8 million New York lives — — Year-to-date, Evofem has gained Phexxi coverage for more than 22.1 million new lives … ugly number in java https://ccfiresprinkler.net

Evofem Announces Successful Debt Restructuring BioSpace

WebAug 4, 2024 · Stifel Downgrades Evofem Biosciences to Hold From Buy, Adjusts Price Target to $0.50 Fr.. MT. 2024. HC Wainwright Adjusts Price Target on Evofem … WebEvofem Biosciences is revolutionizing women’s sexual and reproductive healthcare with a first-in-class innovative hormone-free contraceptive. Evofem’s mission is to empower … About Us - Evofem Biosciences, Inc. (EVFM) - Company Information and … Phexxi ® (lactic acid, citric acid and potassium bitartrate) vaginal gel … Evofem Biosciences’ first commercial product, Phexxi, was recently approved … Clinical Trials - Evofem Biosciences, Inc. (EVFM) - Company Information and … Media Contact - Evofem Biosciences, Inc. (EVFM) - Company Information and … 12400 High Bluff Drive Suite 600 San Diego, California 92130 Phone … Tony O’Brien. Mr. O’Brien has served as a member of the Evofem Biosciences … Together our team launched the first vaginal pH modulator, a unique … ugly noun

EVOFEM BIOSCIENCES, INC. : Press releases EVFM

Category:Evofem Wins Phexxi Coverage with Largest Payer in New York …

Tags:Evofem biosciences investor relations

Evofem biosciences investor relations

Evofem Biosciences Announces Strong Second Quarter 2024 Financial

WebEvofem Biosciences, Inc., (NASDAQ: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). ... Investor Relations Contact. Amy Raskopf. Evofem ... WebApr 12, 2024 · — Improves Phexxi coverage for more than 5.8 million New York lives — — Year-to-date, Evofem has gained Phexxi coverage for more than 22.1 million new lives —. SAN DIEGO , April 12, 2024 /PRNewswire/ -- Evofem Biosciences, Inc., (OTCQB: EVFM) today announced a major new win in New York state that improves coverage for Phexxi® …

Evofem biosciences investor relations

Did you know?

WebSupport: 888-992-3836 Home NewsWire Subscriptions ... WebEvofem Biosciences, Inc., (NASDAQ: EVFM) is developing and commercializing innovative products and product candidates to address unmet needs in women’s sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). Evofem’s sole purpose is to improve ...

WebOct 3, 2024 · PR Newswire. SAN DIEGO, Oct. 3, 2024 /PRNewswire/ -- Evofem Biosciences, Inc., (OTCQB: EVFM) announced today that the trading of its common shares has been upgraded to the OTCQB Venture Market ... WebSep 16, 2024 · Evofem Biosciences, Inc. announced the successful restructuring of its debt, providing forbearance from its debtholders related to all existing events of default. ... The healthcare investor that provided $25 million to Evofem under the April 2024 Securities Purchase and Security Agreement agreed to accept future interest payments as payment …

WebJul 28, 2024 · Evofem Biosciences to Report Second Quarter 2024 Results and Provide Corporate Update on Thursday, August 4, 2024 - read this article along with other … WebAug 11, 2024 · Evofem Biosciences, Inc., (EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, …

WebApr 11, 2024 · 4 brokerages have issued twelve-month target prices for Evofem Biosciences' stock. Their EVFM share price forecasts range from $3.50 to $8.55. On average, they anticipate the company's stock price to reach $5.35 in the next year. This suggests a possible upside of 24,273.6% from the stock's current price. View analysts …

WebMay 4, 2024 · Evofem Biosciences, Inc., (NASDAQ: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and … thomas h raddall libraryWebAug 5, 2024 · Evofem Biosciences, Inc. Q2 2024 Earnings Conference Call August 4, 2024 5:00 PM ETCompany Participants. Amy Raskopf - Vice President-Investor Relations. Saundra Pelletier - Chief Executive ... ugly number listWebMar 3, 2024 · EVOFEM BIOSCIENCES, INC. : Press releases relating to EVOFEM BIOSCIENCES, INC. Investor relations OTC Markets: EVFM OTC Markets thomas hrdlickaWebAug 4, 2024 · Amy Raskopf, Evofem Biosciences’ Head of Investor Relations. Ma'am, please go ahead. Amy Raskopf Thank you, and good morning, everyone. Welcome to … ugly obeseWebOct 26, 2024 · The need is strong - a 2024 report by the World Health Organization (WHO) said that among 1.9 billion reproductive-age women (15 to 49 years) globally in 2024, around 1.1 billion women require family planning and 270 million of those have an unmet need for contraception. Disruptive Contraceptive Patch? The rising … thomas h. ray obituaryWebCurrently, Amy Raskopf holds the position of Head-Investor Relations at Evofem Biosciences, Inc. and Strategic Communications Specialist at In-Site Communications, … ugly number in cWeb12400 High Bluff Drive, Suite 600 San Diego, California 92130 1.858.550.1900 ugly off brand shoes